Beam Therapeutics Has Initiated A Search For A New CFO After Terry-Ann Burrell Shared Plans To Depart On August 9 To Join JPMorgan Chase

7/15/24 6:33:43 AM ET

$BEAM

$JPM

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Major Banks

Finance

Get the next $BEAM alert in real time by email

Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that its chief financial officer, Terry-Ann Burrell, will be leaving the company effective August 9, 2024 to pursue a new opportunity as vice chairman of investment banking at JPMorgan Chase. As part of a transition process, the company has initiated a search for a successor.

Get the next $BEAM alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BEAM
$JPM

Company	Date	Price Target	Rating	Analyst
JP Morgan Chase & Co. $JPM	11/20/2024		Outperform → Perform	Oppenheimer
JP Morgan Chase & Co. $JPM	11/7/2024	$200.00	Neutral → Underperform	Robert W. Baird
Beam Therapeutics Inc. $BEAM	11/6/2024	$27.00 → $39.00	Market Perform → Outperform	Leerink Partners
Beam Therapeutics Inc. $BEAM	10/16/2024		Sector Outperform	Scotiabank
JP Morgan Chase & Co. $JPM	9/30/2024	$220.00 → $224.00	Overweight → Equal-Weight	Morgan Stanley
JP Morgan Chase & Co. $JPM	9/3/2024	$235.00	Buy → Hold	Deutsche Bank
JP Morgan Chase & Co. $JPM	8/20/2024	$240.00	Buy → Outperform	Daiwa Securities
Beam Therapeutics Inc. $BEAM	7/23/2024	$80.00	Buy	H.C. Wainwright

More analyst ratings

JPMorgan Chase Financial Company LLC Declares Quarterly Coupon on Alerian MLP Index ETN
JPMorgan Chase Financial Company LLC announced today the quarterly coupon amount for the Alerian MLP Index ETN (NYSE:AMJB). The table below summarizes the coupon amount for the Alerian MLP Index ETN due January 28, 2044 (the "Notes"). NYSE Arca Ticker Registered Issue Name Declaration Date Ex-Date Record Date Payment Date Coupon Amount1 per Note Current Yield2 AMJB Alerian MLP Index ETN Nov 20, 2024 Nov 29, 2024 Nov 29, 2024 Dec 9, 2024 $0.4502 6.0% 1) As defined in the pricing supplement, dated May 14, 2024 for the Notes. You may access this pricing supplement as follows: https://www.
11/20/24 4:15:00 PM ET
$JPM
Major Banks
Finance
J.D. POWER NAMES TWO SOUTHWEST RAPID REWARDS CREDIT CARDS ISSUED BY CHASE AS THE TOP CO-BRANDED AIRLINE CREDIT CARDS FOR CUSTOMER SATISFACTION
Southwest Rapid Rewards Premier Credit Card ranks No. 1, and the Priority Credit Card ranks No. 2 in Customer Satisfaction DALLAS, Nov. 19, 2024 /PRNewswire/ -- The Southwest Rapid Rewards® Premier and Priority Credit Cards issued by Chase1 are recognized for their commitment to Cardmembers by being named the top two Co-Branded Airline Credit Cards for Customer Satisfaction in the J.D. Power 2024 U.S. Credit Card Customer Satisfaction Study2. The Premier Credit Card is first for Customer Satisfaction among Airline Co-Branded Credit Cards, and the Priority Credit Card is second.
11/19/24 12:04:00 PM ET
$JPM
$LUV
Major Banks
Finance
Air Freight/Delivery Services
Consumer Discretionary
JPMorganChase to Present at the Goldman Sachs U.S. Financial Services Conference
Marianne Lake, CEO of Consumer and Community Banking, will present at the Goldman Sachs U.S. Financial Services Conference at the Conrad Hotel in New York City on Tuesday, December 10, 2024 at 12:20 p.m. (Eastern). A live webcast will be available on the day of the conference at www.jpmorganchase.com under Investor Relations, Events & Presentations. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.2 trillion in assets and $346 billion in stockholders' equity as of September 30, 2024. The Firm is a leader in investment banking, financial services for consumers and small bus
11/12/24 4:28:00 PM ET
$JPM
Major Banks
Finance

$BEAM
$JPM
Financials

Live finance-specific insights

J.P. Morgan Real Estate Income Trust, Inc. Acquires Infill Logistics and Storage Portfolio in Florida's Tampa Market
NEW YORK, Nov. 7, 2024 /PRNewswire/ -- J.P. Morgan Real Estate Income Trust, Inc. (JPMREIT) announced today the acquisition of a strategically positioned two-site, three-building infill logistics and storage portfolio totaling 154,490 square feet located in Tampa and Pinellas Park, FL. The properties are fully leased to PODS, a leading moving and storage company founded and headquartered in the Tampa area. The total purchase price was $25.8 million (exclusive of closing costs). This investment allows JPMREIT to access infill logistics facilities in one of the fastest-growing m
11/7/24 9:15:00 AM ET
$JPM
Major Banks
Finance
Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs
Initial Clinical Data for BEAM-101 and Preclinical Non-human Primate Data for ESCAPE Accepted for Presentation at American Society of Hematology (ASH) Annual Meeting 35 Patients Enrolled and Eight Patients Dosed in BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease First Cohort Dosing Completed in Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency; Initial Clinical Data Expected in 2025 Ended Third Quarter 2024 with $925.8 Million in Cash, Cash Equivalents and Marketable Securities; Expected Operating Runway into 2027 Company to Host Conference Call Today, November 5, 2024, at 8:30 a.m. ET CAMBRIDGE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NA
11/5/24 6:30:00 AM ET
$BEAM
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Beam Therapeutics to Hold Conference Call to Discuss Third Quarter 2024 Financial Results and Abstracts Accepted for Presentation at ASH Annual Meeting
CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the company will host a conference call and webcast on Tuesday, November 5, 2024, at 8:30 a.m. ET to discuss its third quarter 2024 financial results and review the company's abstracts accepted for presentation at the upcoming 66th Annual Meeting of the American Society for Hematology (ASH). A live webcast of the presentation will be available here and under "Events & Presentations" in the Investors section of the company's website at www.beamtx.com. A replay of the webcast will be archived on the com
10/29/24 6:30:00 AM ET
$BEAM
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care

JPMorganChase Elects Brad D. Smith to Its Board of Directors
JPMorganChase (NYSE:JPM) announced today that Brad D. Smith, 60, has been elected as a director of the company, effective January 21, 2025. Mr. Smith has been the President of Marshall University since January 2022. Before returning to serve his alma mater, he was the CEO of Intuit for 11 years where he helped redefine the company from a North American desktop software company to a global cloud-based platform, growing its customer base worldwide through offerings including TurboTax, QuickBooks and Mint. He also served as Chair and Executive Chair of Intuit and held several leadership positions at ADP, PepsiCo, 7UP, and ADVO. His leadership at Intuit was marked by fostering an innovation c
10/17/24 4:26:00 PM ET
$JPM
Major Banks
Finance
J.P. Morgan Private Capital Hires Paris Heymann to Expand Technology Investment Capabilities
Mr. Heymann joins as Managing Partner from Index Ventures NEW YORK, Oct. 15, 2024 /PRNewswire/ -- J.P. Morgan Private Capital, the venture and growth equity investment arm within J.P. Morgan Asset Management, today announced the appointment of Paris Heymann as a new Co-Managing Partner. Mr. Heymann's expertise in late-stage private and crossover investing will broaden the platform's technology investing practice. With strategies across technology, consumer, and life sciences, Private Capital leverages J.P. Morgan's global presence to invest in companies across stage, sector, and geography.
10/15/24 11:00:00 AM ET
$JPM
Major Banks
Finance
J.P. Morgan Asset Management Hires Justin Heller to Join Net Lease Strategy for Real Estate Americas
Heller brings his expertise from TPG Angelo Gordon to expand platform NEW YORK, Oct. 9, 2024 /PRNewswire/ -- J.P. Morgan Asset Management today announced that Justin Heller has joined the firm as Managing Director and Portfolio Manager as part of the net lease strategy for the Real Estate Americas platform. Heller reports directly to Chad Tredway, Managing Partner for the net lease strategy and Head of Real Estate Americas. This strategic hire emphasizes the firm's commitment to expanding its real estate product offerings, and growing the business by sourcing new investment opportunities.
10/9/24 10:00:00 AM ET
$JPM
Major Banks
Finance

Behind the Scenes of JPMorgan Chase's Latest Options Trends
Deep-pocketed investors have adopted a bearish approach towards JPMorgan Chase (NYSE:JPM), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in JPM usually suggests something big is about to happen. We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for JPMorgan Chase. This level of activity is out of the ordinary. The general mood among these heavyweight investors is divided, with 37% leaning bullish and 50% bearish. Among these notable option
7/25/24 10:18:57 AM ET
$JPM
Major Banks
Finance
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Tuesday. Shares of Danaher Corporation (NYSE:DHR) rose sharply during Tuesday's session after the company reported better-than-expected second quarter earnings. Danaher's second quarter sales decreased 3% year-over-year to $5.743 billion, beating the consensus of $5.59 billion. Danaher reported second-quarter adjusted EPS of $1.72, beating the consensus of $1.57, according to data from Benzinga Pro. Danaher shares gained 7.4% to $269.35 on Tuesday. Here are some other big stocks recording gains in today’s session. Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) shares jumped 16% to $24.81 af
7/23/24 11:04:22 AM ET
$BEAM
$BRO
$CCK
$DHR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Specialty Insurers
Finance
Beam Therapeutics shares are trading higher after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and announced an $80 price target.
7/23/24 10:55:21 AM ET
$BEAM
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care

Beam Therapeutics Has Initiated A Search For A New CFO After Terry-Ann Burrell Shared Plans To Depart On August 9 To Join JPMorgan Chase

Chat with this insight

Recent Analyst Ratings for $BEAM$JPM

$BEAM$JPM Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Co-CEO CIB Rohrbaugh Troy L gifted 12,362 shares, decreasing direct ownership by 7% to 175,781 units (SEC Form 4)

CEO Asset & Wealth Management Erdoes Mary E. gifted 2,100 shares, decreasing direct ownership by 0.36% to 583,798 units (SEC Form 4)

President Ciaramella Giuseppe sold $1,347,050 worth of shares (51,110 units at $26.36), decreasing direct ownership by 32% to 109,150 units (SEC Form 4)

$BEAM$JPM Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

JPMorgan Chase downgraded by Oppenheimer

JPMorgan Chase downgraded by Robert W. Baird with a new price target

Beam Therapeutics upgraded by Leerink Partners with a new price target

$BEAM$JPM Press Releases

Fastest customizable press release news feed in the world

JPMorgan Chase Financial Company LLC Declares Quarterly Coupon on Alerian MLP Index ETN

J.D. POWER NAMES TWO SOUTHWEST RAPID REWARDS CREDIT CARDS ISSUED BY CHASE AS THE TOP CO-BRANDED AIRLINE CREDIT CARDS FOR CUSTOMER SATISFACTION

JPMorganChase to Present at the Goldman Sachs U.S. Financial Services Conference

$BEAM$JPM Financials

Live finance-specific insights

J.P. Morgan Real Estate Income Trust, Inc. Acquires Infill Logistics and Storage Portfolio in Florida's Tampa Market

Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs

Beam Therapeutics to Hold Conference Call to Discuss Third Quarter 2024 Financial Results and Abstracts Accepted for Presentation at ASH Annual Meeting

$BEAM$JPM Leadership Updates

Live Leadership Updates

JPMorganChase Elects Brad D. Smith to Its Board of Directors

J.P. Morgan Private Capital Hires Paris Heymann to Expand Technology Investment Capabilities

J.P. Morgan Asset Management Hires Justin Heller to Join Net Lease Strategy for Real Estate Americas

$BEAM$JPM Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Beam Therapeutics Inc.

Amendment: SEC Form SC 13G/A filed by Beam Therapeutics Inc.

Amendment: SEC Form SC 13G/A filed by Beam Therapeutics Inc.

$BEAM$JPM Market Insights

Live Market Insights

$BEAM$JPM SEC Filings

Behind the Scenes of JPMorgan Chase's Latest Options Trends

Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday

Beam Therapeutics shares are trading higher after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and announced an $80 price target.

SEC Form FWP filed by JP Morgan Chase & Co.

SEC Form FWP filed by JP Morgan Chase & Co.

SEC Form FWP filed by JP Morgan Chase & Co.

Recent Analyst Ratings for
$BEAM
$JPM

$BEAM
$JPM
Insider Trading

$BEAM
$JPM
Analyst Ratings

$BEAM
$JPM
Press Releases

$BEAM
$JPM
Financials

$BEAM
$JPM
Leadership Updates

$BEAM
$JPM
Large Ownership Changes

$BEAM
$JPM
Market Insights

$BEAM
$JPM
SEC Filings